Twitter chat on genomics and precision medicine
Recently, the National Cancer Institute hosted a Twitter on “Genomics and Precision Medicine in Oncology.” VCU Massey Cancer Center medical oncologist Andrew Poklepovic, M.D., who is also a member of the Developmental Therapeutics research program at Massey and assistant professor in the Division of Hematology, Oncology and Palliative Care at the VCU School of Medicine, weighed in as the moderator posed a series of questions.
Massey scientists uncover process that could drive the majority of cancers
The gene p53 has been described as the “guardian of the genome” due to its prominent role in preventing genetic mutations. More than half of all cancers are thought to originate from p53 mutations or loss of function, and now a recent study by VCU Massey Cancer Center scientist Richard Moran, Ph.D., explains why.
Expert Q&A on immunotherapy with Giao Q. Phan
Former President Jimmy Carter announced this week that he is cancer free after undergoing a cutting-edge approach to cancer treatment known as immunotherapy. Massey surgical oncologist and member of the Developmental Therapeutics research program Giao Q. Phan, M.D., F.A.C.S., specializes in immunotherapy and sat down to answer some questions on the subject.
Twitter chat on Cancer Health Disparities
Recently, the National Cancer Institute hosted a Twitter chat entitled, “A Holistic Approach to Addressing Cancer Health Disparities.” The discussion focused on accelerating progress in research to address this serious public health issue, and VCU Massey Cancer Center researcher, Andrew Barnes, Ph.D., a member of the Cancer Prevention and Control research program at Massey and assistant professor in the Department of Health Behavior and Policy, weighed in as the moderator posed a series of questions.
Dethroning lung cancer: How Massey is working to improve survival of the deadliest form of cancer
Richmond’s only National Cancer Institute-designated cancer center, VCU Massey Cancer Center is discovering new and better ways to prevent, detect and treat lung cancer. It will take new, innovative treatments, early detection and an eye toward prevention to save lives, and our doctors and researchers are stepping up to the challenge in a variety of ways.